BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 23598979)

  • 1. CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.
    Williams K; Motiani K; Giridhar PV; Kasper S
    Exp Biol Med (Maywood); 2013 Mar; 238(3):324-38. PubMed ID: 23598979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.
    Bourguignon LY; Shiina M; Li JJ
    Adv Cancer Res; 2014; 123():255-75. PubMed ID: 25081533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 splice isoform switching determines breast cancer stem cell state.
    Zhang H; Brown RL; Wei Y; Zhao P; Liu S; Liu X; Deng Y; Hu X; Zhang J; Gao XD; Kang Y; Mercurio AM; Goel HL; Cheng C
    Genes Dev; 2019 Feb; 33(3-4):166-179. PubMed ID: 30692202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan-CD44 axis orchestrates cancer stem cell functions.
    Skandalis SS; Karalis TT; Chatzopoulos A; Karamanos NK
    Cell Signal; 2019 Nov; 63():109377. PubMed ID: 31362044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44: structure, function, and association with the malignant process.
    Naor D; Sionov RV; Ish-Shalom D
    Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CD44v
    Hu J; Li G; Zhang P; Zhuang X; Hu G
    Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
    Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
    Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line.
    Asai R; Tsuchiya H; Amisaki M; Makimoto K; Takenaga A; Sakabe T; Hoi S; Koyama S; Shiota G
    Cancer Med; 2019 Feb; 8(2):773-782. PubMed ID: 30636370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression.
    Bourguignon LY; Zhu D; Zhu H
    Front Biosci; 1998 Jul; 3():d637-49. PubMed ID: 9634539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
    Olsson E; Honeth G; Bendahl PO; Saal LH; Gruvberger-Saal S; Ringnér M; Vallon-Christersson J; Jönsson G; Holm K; Lövgren K; Fernö M; Grabau D; Borg A; Hegardt C
    BMC Cancer; 2011 Sep; 11():418. PubMed ID: 21957977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Pericellular Matrix in the Regulation of Cancer Stemness.
    Avnet S; Cortini M
    Stem Cell Rev Rep; 2016 Aug; 12(4):464-75. PubMed ID: 27193782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan-CD44 interactions as potential targets for cancer therapy.
    Misra S; Heldin P; Hascall VC; Karamanos NK; Skandalis SS; Markwald RR; Ghatak S
    FEBS J; 2011 May; 278(9):1429-43. PubMed ID: 21362138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JNK Signaling in Stem Cell Self-Renewal and Differentiation.
    Semba T; Sammons R; Wang X; Xie X; Dalby KN; Ueno NT
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44: A Multifunctional Mediator of Cancer Progression.
    Hassn Mesrati M; Syafruddin SE; Mohtar MA; Syahir A
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth.
    Pietras A; Katz AM; Ekström EJ; Wee B; Halliday JJ; Pitter KL; Werbeck JL; Amankulor NM; Huse JT; Holland EC
    Cell Stem Cell; 2014 Mar; 14(3):357-69. PubMed ID: 24607407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis.
    Bourrguignon LY; Iida N; Welsh CF; Zhu D; Krongrad A; Pasquale D
    J Neurooncol; 1995 Dec; 26(3):201-8. PubMed ID: 8750186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of CD44 and Cancer Stem Cells.
    Wang L; Zuo X; Xie K; Wei D
    Methods Mol Biol; 2018; 1692():31-42. PubMed ID: 28986884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
    Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
    Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.